Immunogenicity and safety assessment of a trivalent, inactivated split influenza vaccine in Korean children: Double-blind, randomized, active-controlled multicenter phase III clinical trial

A multicenter, double-blind, randomized, active-control phase III clinical trial was performed to assess the immunogenicity and safety of a trivalent, inactivated split influenza vaccine. Korean children between the ages of 6 months and 18 y were enrolled and randomized into a study (study vaccine)...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Seung Beom, Rhim, Jung-Woo, Shin, Hye Jo, Lee, Soo Young, Kim, Hyun-Hee, Kim, Jong-Hyun, Lee, Kyung-Yil, Ma, Sang Hyuk, Park, Joon Soo, Kim, Hwang Min, Kim, Chun Soo, Kim, Dong Ho, Choi, Young Youn, Cha, Sung-Ho, Hong, Young Jin, Kang, Jin Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514431/
https://www.ncbi.nlm.nih.gov/pubmed/25875868
http://dx.doi.org/10.1080/21645515.2015.1017693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514431/
https://www.ncbi.nlm.nih.gov/pubmed/25875868
http://dx.doi.org/10.1080/21645515.2015.1017693

Ejemplares similares